Werewolf Therapeutics Inc

NASDAQ:HOWL   4:00:00 PM EDT
6.35
+0.31 (+5.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)271.38M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.82 Million
Adjusted EPS-$0.34
See more estimates
10-Day MA$6.20
50-Day MA$6.02
200-Day MA$3.64
See more pivots

Werewolf Therapeutics Inc Stock, NASDAQ:HOWL

200 Talcott Avenue, 2nd floor, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.952.0555
Number of Employees: 47

Description

Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body�s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.